Therapeutic strategies for COVID-19 patients are complex, and so the synergistic effects of BTK, FLT3, and EGFR in ALI should also be highlighted in the development of broad-spectrum antiviral compounds that boost the innate response. The gene discussed is FLT3; the disease is acute respiratory distress syndrome.